ROZLYTREK

ROZLYTREK

Displaying 10 out of 2 results

  1. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche cancer treatment priced at US$17,050 a month, lower than rival Vitrakvi

    Roche Holding AG priced at about US$204,560 a year its personalized cancer treatment, Rozlytrek, which targets tumors with specific genetic ...
  2. The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co

    Roche's personalized cancer treatment wins FDA approval

    The U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.